259 related articles for article (PubMed ID: 35794547)
1. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
2. Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group.
Schneider R; Reinau D; Stoffel S; Jick SS; Meier CR; Spoendlin J
Br J Dermatol; 2021 Aug; 185(2):343-352. PubMed ID: 33609289
[TBL] [Abstract][Full Text] [Related]
3. The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis.
Heisel AGU; Vuurboom MD; Daams JG; de Rie MA; Vogt L; van den Born BH; Olde Engberink RHG
Vascul Pharmacol; 2023 Jun; 150():107173. PubMed ID: 37084802
[TBL] [Abstract][Full Text] [Related]
4. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
5. Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide.
Ernst ME; Fravel MA
Am J Hypertens; 2022 Jul; 35(7):573-586. PubMed ID: 35404993
[TBL] [Abstract][Full Text] [Related]
6. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
7. Association Between the Use of Thiazide Diuretics and the Risk of Skin Cancers: A Meta-Analysis of Observational Studies.
Shin D; Lee ES; Kim J; Guerra L; Naik D; Prida X
J Clin Med Res; 2019 Apr; 11(4):247-255. PubMed ID: 30937114
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.
Peterzan MA; Hardy R; Chaturvedi N; Hughes AD
Hypertension; 2012 Jun; 59(6):1104-9. PubMed ID: 22547443
[TBL] [Abstract][Full Text] [Related]
9. Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis.
Nochaiwong S; Chuamanochan M; Ruengorn C; Noppakun K; Awiphan R; Phosuya C; Tovanabutra N; Chiewchanvit S; Sood MM; Hutton B; Thavorn K; Knoll GA
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626169
[TBL] [Abstract][Full Text] [Related]
10. Thiazide diuretics as chronic antihypertensive therapy in patients with severe renal disease--is there a role in the absence of diuresis?
Chan CY; Peterson EJ; Ng TM
Ann Pharmacother; 2012 Nov; 46(11):1554-8. PubMed ID: 23136355
[TBL] [Abstract][Full Text] [Related]
11. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.
Roush GC; Abdelfattah R; Song S; Ernst ME; Sica DA; Kostis JB
J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1507-1515. PubMed ID: 30251403
[TBL] [Abstract][Full Text] [Related]
12. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
Park E; Lee Y; Jue MS
Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
[TBL] [Abstract][Full Text] [Related]
13. The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.
Macfarlane TV; Pigazzani F; Flynn RWV; MacDonald TM
Br J Clin Pharmacol; 2019 Feb; 85(2):285-303. PubMed ID: 30312512
[TBL] [Abstract][Full Text] [Related]
14. Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population?
Carney K; Cousins M
Evid Based Dent; 2022 Mar; 23(1):38-39. PubMed ID: 35338330
[TBL] [Abstract][Full Text] [Related]
15. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides.
Ames RP
Am J Cardiol; 1996 Feb; 77(6):12b-16b. PubMed ID: 8848987
[TBL] [Abstract][Full Text] [Related]
16. Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis.
Gandini S; Palli D; Spadola G; Bendinelli B; Cocorocchio E; Stanganelli I; Miligi L; Masala G; Caini S
Crit Rev Oncol Hematol; 2018 Feb; 122():1-9. PubMed ID: 29458778
[TBL] [Abstract][Full Text] [Related]
17. Melanoma and Non-Melanoma Skin Cancer Associated with Angiotensin-Converting-Enzyme Inhibitors, Angiotensin-Receptor Blockers and Thiazides: A Matched Cohort Study.
Nardone B; Majewski S; Kim AS; Kiguradze T; Martinez-Escala EM; Friedland R; Amin A; Laumann AE; Edwards BJ; Rademaker AW; Martini MC; West DP
Drug Saf; 2017 Mar; 40(3):249-255. PubMed ID: 27943160
[TBL] [Abstract][Full Text] [Related]
18. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW;
J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517
[TBL] [Abstract][Full Text] [Related]
19. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study.
Lecaros-Astorga DA; Molina-Guarneros JA; Rodríguez-Jiménez P; Martin-Arias LH; Sainz-Gil M
Int J Clin Pharmacol Ther; 2021 Apr; 59(4):280-288. PubMed ID: 33355085
[TBL] [Abstract][Full Text] [Related]
20. The effect of menopausal hormone therapy on the risk of melanoma and keratinocyte skin cancer: A systematic review and meta-analysis of observational studies.
Lallas K; Anagnostis P; Theocharis P; Boureka E; Kyrgidis A; Klonos E; Papazisis G; Apalla Z; Lallas A; Vakirlis E
Maturitas; 2023 Feb; 168():20-28. PubMed ID: 36372010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
